Funding, News and Announcements

Pfizer intends to support Quality Improvement (QI) initiatives that focus on improving and/or optimizing COVID-19 treatment strategies in elderly vulnerable populations in Canada (e.g., in private and/or public long-term care centers, nursing homes, etc.), where COVID-19 could have severe outcomes and viral outbreaks are more common. Particular consideration will be given to projects intended to improve COVID-19 treatment in underrepresented populations such as new immigrants, visible minorities, older patients in rural and remote areas, First Nations, Métis, Inuit, or other underrepresented communities.

Individual projects requesting up to $75,000 CAD will be considered.

Project length will be a maximum of 18 months. Click here for more details [PDF].

For questions, contact ird@Dal.ca. For additional resources, click here for guidance on internal deadlines and submission processes.

Internal Deadline: August 9, 2023 at 4:30pm
Funder Deadline: August 23, 2023